Related Experiment Videos
Amiodarone minimizes experimental autoimmune myocarditis in rats
Shinobu Matsui1, Zhi-Ping Zong, Jian-Feng Han
1Department of Cardiology, Kanazawa Medical University, Uchinada, Ishikawa 920-0293, Japan.
European Journal of Pharmacology
|June 5, 2003
Summary
Amiodarone treatment reduced heart inflammation and fibrosis in rats with experimental autoimmune myocarditis. This suggests amiodarone may help treat myocarditis, particularly when combined with cardiac arrhythmias.
Area of Science:
- Immunology
- Cardiology
- Pharmacology
Background:
- Amiodarone, an antiarrhythmic drug, exhibits in vitro immunomodulatory effects.
- Myocarditis is an inflammatory heart condition often associated with arrhythmias.
Purpose of the Study:
- To investigate the in vivo immunomodulatory effects of amiodarone.
- To evaluate amiodarone's therapeutic potential in experimental autoimmune myocarditis.
Main Methods:
- Experimental autoimmune myocarditis was induced in rats via cardiac myosin immunization.
- Amiodarone (25 mg/kg) was administered intraperitoneally every other day for 10 doses post-induction.
- Histological, macroscopic, and lymphocyte phenotyping analyses were performed.
Main Results:
- Amiodarone treatment led to reduced heart weight, inflammation, and fibrosis.
- A significant decrease in the peripheral blood CD4/CD8a lymphocyte ratio was observed.
- A lower proportion of mast cells in inflammatory infiltrates and inhibited mast cell proliferation in vitro were noted.
Conclusions:
- Amiodarone effectively minimized experimental autoimmune myocarditis progression in rats.
- Amiodarone's immunomodulatory effects on T cells and mast cells may underlie its protective mechanism.
- Amiodarone shows potential as a therapeutic agent for myocarditis, especially in patients with cardiac arrhythmias.